Home > M&A deals 2018 > Locus Biosciences, Inc. acquires EpiBiome, Inc. - Bacteriophage Platform
Divestiture · Life Science · July 2018

Locus Biosciences, Inc. acquires EpiBiome, Inc. - Bacteriophage Platform

On July 17, 2018, Locus Biosciences, Inc. acquired EpiBiome, Inc. - Bacteriophage Platform, a life science company in California, United States.

Deal at a glance

AnnouncedJuly 17, 2018 TypeDivestiture TargetEpiBiome, Inc. - Bacteriophage Platform Buyer Locus Biosciences, Inc. SectorLife Science LocationCalifornia, United States ValueNot disclosed

Target company

EpiBiome, Inc. - Bacteriophage Platform
California, United States
Life Sciencesector
-founded
Activestatus
View the company profile →

Buyer

Locus Biosciences, Inc.
Company · 1 deal on record
  • 1st transaction in life science
  • 1st transaction in United States
1deals, all time
1in this sector
2018latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Orbus Therapeutics, Inc.Same sector and country · Oct 2026
ArtesRx LLCSame sector and country · Aug 2026
Firefly Bio, Inc.Same sector and country · Jul 2026

Questions about this deal

Who acquired EpiBiome, Inc. - Bacteriophage Platform?Locus Biosciences, Inc. acquired EpiBiome, Inc. - Bacteriophage Platform on July 17, 2018.

What type of deal was it?It was a divestiture in the life science sector in 2018.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).